Gene · 1672
Papers3,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. | Science | 2021 | 33446526 | PubTator, text mining | PubMed |
| Potential Suppressive Effect of Nicotine on the Inflammatory Response in Oral Epithelial Cells: An In Vitro Study. | Int J Environ Res Public Health | 2021 | 33435295 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Equine and Viral Genes in Peripheral Blood Mononuclear Cells in Horses during Equine Herpesvirus 1 Infection. | Pathogens | 2021 | 33430330 | PubTator, text mining | PubMed |
| Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia. | Nature | 2021 | 33429418 | PubTator, text mining | PubMed |
| Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota. | Commun Biol | 2021 | 33420317 | PubTator, text mining | PubMed |
| Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure. | Retrovirology | 2021 | 33413475 | PubTator, text mining | PubMed |
| Declined expressing mRNA of beta-defensin 108 from epididymis is associated with decreased sperm motility in blue fox (Vulpes lagopus). | BMC Vet Res | 2021 | 33413374 | PubTator, text mining | PubMed |
| Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system. | Virchows Arch | 2021 | 33398430 | PubTator, text mining | PubMed |
Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis. | J King Saud Univ Sci | 2021 | 33390681 | PubTator, text mining | PubMed |
| Plasticity of distal nephron epithelia from human kidney organoids enables the induction of ureteric tip and stalk. | Cell Stem Cell | 2021 | 33378647 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals heterogeneity and differential expression of decidual tissues during the peripartum period. | Cell Prolif | 2021 | 33300223 | PubTator, text mining | PubMed |
| Scanning Protein Surfaces with DNA-Encoded Libraries. | ChemMedChem | 2021 | 33295694 | PubTator, text mining | PubMed |
| Beta-defensin 1 gene polymorphisms in the pathologies of the oral cavity-Data from meta-analysis: Association only with rs1047031 not with rs1800972, rs1799946, and rs11362. | J Oral Pathol Med | 2021 | 33231892 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Expression of antimicrobial peptide genes oscillates along day/night rhythm protecting mice skin from bacteria. | Exp Dermatol | 2021 | 33131146 | PubTator, text mining | PubMed |
| Selective N-Terminal BET Bromodomain Inhibitors by Targeting Non-Conserved Residues and Structured Water Displacement*. | Angew Chem Int Ed Engl | 2021 | 32975004 | PubTator, text mining | PubMed |
| Activation of the Innate Immune System in Children With Irritable Bowel Syndrome Evidenced by Increased Fecal Human β-Defensin-2. | Clin Gastroenterol Hepatol | 2021 | 32961343 | PubTator, text mining | PubMed |
| Leveraging orthogonal mass spectrometry based strategies for comprehensive sequencing and characterization of ribosomal antimicrobial peptide natural products. | Nat Prod Rep | 2021 | 32929442 | PubTator, text mining | PubMed |
| Inhibitors of bromodomain and extra-terminal proteins for treating multiple human diseases. | Med Res Rev | 2021 | 32926459 | PubTator, text mining | PubMed |
| COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy. | Stem Cell Rev Rep | 2021 | 32920752 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1672/papers?page=55